| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 |
|---|---|---|---|---|---|---|
Revenues: | ||||||
Revenue | ||||||
1,134,468 | 650,067 | 399,020 | 277,335 | 166,919 | 88,846 | 49,920 |
Cost of revenue | ||||||
525,551 | 300,841 | 182,895 | 120,520 | 74,454 | 41,423 | 25,868 |
Gross profit | ||||||
608,917 | 349,226 | 216,125 | 156,815 | 92,465 | 47,423 | 24,052 |
Operating expenses: | ||||||
Research and development | ||||||
391,355 | 171,358 | 120,739 | 77,926 | 42,559 | 21,824 | 13,959 |
Sales and marketing | ||||||
369,079 | 175,555 | 100,669 | 65,267 | 49,308 | 33,322 | 21,931 |
General and administrative | ||||||
218,268 | 117,548 | 60,791 | 51,077 | 35,991 | 18,960 | 15,012 |
Charitable contribution | ||||||
- | - | - | 3,860 | - | - | - |
Total operating expenses | ||||||
978,702 | 464,461 | 282,199 | 198,130 | 127,858 | 74,106 | 50,902 |
Loss from operations | ||||||
-369,785 | -115,235 | -66,074 | -41,315 | -35,393 | -26,683 | -26,850 |
Other expenses, net | ||||||
7,569 | -5,923 | 3,071 | 317 | 11 | -62 | -4 |
Loss before (provision) benefit for income taxes | ||||||
-362,216 | -121,158 | -63,003 | -40,998 | -35,382 | -26,745 | -26,854 |
(Provision) benefit for income taxes | ||||||
-55,153 | 791 | 705 | 326 | 122 | 13 | - |
Net loss | ||||||
- | - | - | - | -35,504 | -26,758 | -26,854 |
Deemed dividend to investors in relation to tender offer | ||||||
- | - | - | - | 3,392 | - | - |
Net loss attributable to common stockholders | ||||||
-307,063 | -121,949 | -63,708 | -41,324 | -38,896 | -26,758 | -26,854 |
Net loss per share attributable to common stockholders, basic and diluted (in dollars per share) | ||||||
-2.36 | -1.26 | -0.70 | -0.78 | -2.19 | -1.58 | -1.59 |
Weighted-average shares used to compute net loss per share attributable to common stockholders, basic and diluted (in shares) | ||||||
130,083 | 97,130 | 91,224 | 53,116 | 17,746 | 16,900 | 16,916 |